Omnicell, Inc. (OMCL)
NASDAQ: OMCL · IEX Real-Time Price · USD
26.16
-0.49 (-1.84%)
At close: Jul 2, 2024, 4:00 PM
25.65
-0.51 (-1.95%)
After-hours: Jul 2, 2024, 4:04 PM EDT
Omnicell Revenue
Omnicell had revenue of $1.10B in the twelve months ending March 31, 2024, down -13.02% year-over-year. Revenue in the quarter ending March 31, 2024 was $246.15M, a -15.30% decrease year-over-year. In the year 2023, Omnicell had annual revenue of $1.15B, a decrease of -11.48%.
Revenue (ttm)
$1.10B
Revenue Growth
-13.02%
P/S Ratio
1.09
Revenue / Employee
$302,092
Employees
3,650
Market Cap
1.20B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.15B | -148.84M | -11.48% |
Dec 31, 2022 | 1.30B | 163.93M | 14.48% |
Dec 31, 2021 | 1.13B | 239.81M | 26.88% |
Dec 31, 2020 | 892.21M | -4.82M | -0.54% |
Dec 31, 2019 | 897.03M | 109.72M | 13.94% |
Dec 31, 2018 | 787.31M | 74.60M | 10.47% |
Dec 31, 2017 | 712.71M | 16.81M | 2.41% |
Dec 31, 2016 | 695.91M | 211.35M | 43.62% |
Dec 31, 2015 | 484.56M | 43.66M | 9.90% |
Dec 31, 2014 | 440.90M | 60.32M | 15.85% |
Dec 31, 2013 | 380.59M | 66.56M | 21.19% |
Dec 31, 2012 | 314.03M | 68.49M | 27.90% |
Dec 31, 2011 | 245.54M | 23.13M | 10.40% |
Dec 31, 2010 | 222.41M | 8.95M | 4.19% |
Dec 31, 2009 | 213.46M | -38.41M | -15.25% |
Dec 31, 2008 | 251.87M | 38.78M | 18.20% |
Dec 31, 2007 | 213.08M | 58.37M | 37.73% |
Dec 31, 2006 | 154.71M | 33.19M | 27.31% |
Dec 31, 2005 | 121.52M | -2.42M | -1.95% |
Dec 31, 2004 | 123.94M | 21.81M | 21.36% |
Dec 31, 2003 | 102.13M | 14.44M | 16.46% |
Dec 31, 2002 | 87.69M | 789.00K | 0.91% |
Dec 31, 2001 | 86.90M | 19.54M | 29.00% |
Dec 31, 2000 | 67.37M | 12.09M | 21.88% |
Dec 31, 1999 | 55.27M | 7.06M | 14.64% |
Dec 31, 1998 | 48.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Phreesia | 373.67M |
Xencor | 162.18M |
Establishment Labs Holdings | 155.79M |
Immatics | 80.95M |
Vir Biotechnology | 79.60M |
Spyre Therapeutics | 688.00K |
OMCL News
- 2 months ago - Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation - Business Wire
- 2 months ago - Omnicell to Present at the BofA Securities 2024 Health Care Conference - Business Wire
- 2 months ago - Omnicell Announces First Quarter 2024 Results - Business Wire
- 2 months ago - Omnicell Announces XT Amplify - Business Wire
- 3 months ago - Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 4 months ago - Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum - Business Wire
- 5 months ago - Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results - Business Wire
- 6 months ago - Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024 - Business Wire